XML 18 R2.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 24,289 $ 44,812
Marketable securities available-for-sale 57,126 151,313
Accounts and other receivables 1,342 1,394
Prepaid expenses and other current assets 6,842 2,427
Total current assets 89,599 199,946
Property and equipment, net 17,174 13,804
Goodwill 1,971 2,043
Restricted cash 602 609
Other assets 334 231
Total assets 109,680 216,633
Current liabilities:    
Accounts payable 3,796 3,433
Accrued research and development 5,048 7,361
Accrued liabilities 11,192 15,337
Deferred revenues   2,654
Total current liabilities 20,036 28,785
Other long-term liabilities 443 769
Total liabilities 20,479 29,554
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Preferred stock: $0.001 par value; 5,000 shares authorized at December 31, 2016 and December 31, 2015; no shares issued and outstanding at December 31, 2016 and December 31, 2015
Common stock: $0.001 par value; 69,500 shares authorized at December 31, 2016 and 2015; 38,599 and 38,446 shares issued and outstanding at December 31, 2016 and 2015, respectively 39 38
Additional paid-in capital 904,957 889,698
Accumulated other comprehensive loss (3,624) (2,930)
Accumulated deficit (812,171) (699,727)
Total stockholders’ equity 89,201 187,079
Total liabilities and stockholders’ equity $ 109,680 $ 216,633